Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  05/20/2003
 
Trade Name:  Duragesic
 
Generic Name or Proper Name (*):  fentanyl
 
Indications Studied:  Management of chronic pain
 
Label Changes Summary:  Safety evaluated in three open-label trials in 291 patients 2 years through 18 years of age with chronic pain New Warning: Duragesic should be administered to children only if they are opioid-tolerant and age 2 years or older New information on pharmacokinetics, dosage and administration and patient information Precaution to guard against accidental ingestions by children Adverse Events: no apparent pediatric-specific risk associated with Duragesic use in children as young as 2 years old when used as directed. Most common adverse events were fever (35%), vomiting (33%), and nausea (24%)
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B):  B
 
Sponsor:  Alza
 
Pediatric Exclusivity Granted Date:  01/29/2003
 
NNPS:  FALSE'
 
Therapeutic Category:  Anesthetic agent
 
-
-